Literature DB >> 30991

Serological diagnosis of pneumococcal disease with enzyme-linked immunosorbent assay (ELISA).

E Berntsson, K A Broholm, B Kaijser.   

Abstract

Antibody response to pneumococcal type-specific polysaccharide was measured with enzyme-linked immunosorbent assay (ELISA). The test was shown to be up to 500 times more sensitive than indirect hemagglutination using chromic chloride-treated red blood cells. In 16/17 patients with pneumococcal pneumonia a significant antibody increase was seen as measured with ELISA. Only 6/23 patients with pneumonia caused by Mycoplasma pneumoniae gave a pneumococcal antibody rise and in those cases the increase was very slight. The authors consider ELISA a valuable contribution to the serological diagnosis of pneumococcal disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30991     DOI: 10.3109/inf.1978.10.issue-3.04

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  20 in total

1.  Principles, problems, and strategies in the use of antigenic mixtures for the enzyme-linked immunosorbent assay.

Authors:  G E Kenny; C L Dunsmoor
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

2.  Comparison of ELISA and RIA for measurement of pneumococcal antibodies before and after vaccination with 14-valent pneumococcal capsular polysaccharide vaccine.

Authors:  M Koskela; M Leinonen
Journal:  J Clin Pathol       Date:  1981-01       Impact factor: 3.411

3.  Indirect sandwich enzyme-linked immunosorbent assay for rapid detection of Streptococcus pneumoniae type 3 antigen.

Authors:  D L Drow; D D Manning
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

4.  Enzyme-linked immunosorbent assay for detection of antibodies against Streptococcus pneumoniae capsular polysaccharides.

Authors:  H Russell; L R Edwards; E W Wortham; R R Facklam
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

5.  Detection of antibodies to pneumococcal capsular polysaccharides by enzyme-linked immunosorbent assay.

Authors:  F K Pedersen; J Henrichsen
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

6.  Determination of antibodies to pneumococcal C polysaccharide in patients with community-acquired pneumonia.

Authors:  H Holmberg; A Krook; A M Sjögren
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

7.  Etiology of community-acquired pneumonia in patients requiring hospitalization.

Authors:  E Berntsson; J Blomberg; T Lagergård; B Trollfors
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

8.  Isolation and characterization of circulating immune complexes from patients with pneumococcal pneumonia.

Authors:  M A Mellencamp; L C Preheim; T L McDonald
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

9.  Demonstration of circulating pneumococcal immunoglobulin G immune complexes in patients with community-acquired pneumonia by means of an enzyme-linked immunosorbent assay.

Authors:  Y Holloway; J A Snijder; W G Boersma
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

10.  Pneumococcal antibodies (IgG, IgM) in patients with chronic obstructive lung disease 3 years after pneumococcal vaccination.

Authors:  C Kraus; S Fischer; R Ansorg; U Hüttemann
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.